Alvotech ALVO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $3.74
- Day Range
- $3.48–3.73
- 52-Week Range
- $2.94–10.80
- Bid/Ask
- $3.70 / $3.92
- Shares Outstanding
- 312.05M
- Market Cap
- $1.10B
- Volume/Avg
- 24,830 / 513,483
Key Statistics
- Price/Earnings (Normalized)
- 37.62
- Price/Sales
- 1.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,460
- Website
- https://www.alvotech.com
Valuation
|
Metric
|
ALVO
|
|---|---|
Price/Earnings (Normalized) | 37.62 |
Price/Book Value | — |
Price/Sales | 1.76 |
Price/Cash Flow | 15.29 |
Price/Earnings
ALVO
Financial Strength
|
Metric
|
ALVO
|
|---|---|
Quick Ratio | 1.07 |
Current Ratio | 1.89 |
Interest Coverage | 1.98 |
Quick Ratio
ALVO
Profitability
|
Metric
|
ALVO
|
|---|---|
Return on Assets (Normalized) | −10.00% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −2.22% |
Return on Assets
ALVO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Qzmsnxcss | Hfqcsp | $69B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Vwtppjgcj | Kxsgdsm | $40B | |||
| Haleon PLC ADR
HLN
| Xbsxjpm | Jfzjp | $40B | |||
| Zoetis Inc Class A
ZTS
| Hnqdmqjkqw | Pkyd | $33B | |||
| Viatris Inc
VTRS
| Lyhlhgxyw | Qkc | $18B | |||
| Elanco Animal Health Inc
ELAN
| Dzz | Rbps | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Rdfkyys | Ybglx | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| Zhcynndv | Byzz | $6B | |||
| Curaleaf Holdings Inc
CURLD
| Kxlzjldpw | Mrhw | $3B | |||
| Prestige Consumer Healthcare Inc
PBH
| Fzvhkmmk | Prtzkv | $2B |
United States